As the pharmaceutical developers transition from blockbuster APIs to niche busters, they are facing new challenges with formulating poorly absorbable APIs. This webcast will provide a brief overview of the market dynamics and discuss in detail possible oral dosage form solutions to help overcome challenges with bioavailability and absorption of complex drug formulations. Key Learning Objectives:
Who Should Watch: Research and development scientists, formulation scientists
Latest CHI content